Current concepts in transarterial chemoembolization of hepatocellular carcinoma
Author:
- 15 June 2011
- journal article
- review article
- Published by Springer Nature in Abdominal Radiology
- Vol. 36 (6) , 677-683
Abstract
Transarterial chemoembolization (TACE) has the potential to improve survival in patients with intermediate stage hepatocellular carcinoma (HCC). Careful selection of patients is mandatory to gain survival benefit and safe quality of life. Basic principles of TACE in HCC include selective treatment via intrahepatic and extrahepatic arteries, proper management of side effects and continuation of treatment guided by imaging. After conventional TACE, based on delivery of cytotoxic drugs emulsified in iodized oil and embolization of various types of particles, has been used for more than 20 years, the new concept of drug-eluting microspheres has been introduced. This technology effectively combines enhanced local drug delivery and ischemic embolization effects. Clinical studies showed intensified local necroses and reduced systemic toxic side effects compared to conventional TACE. Embolization of HCC with sub-100 μm particles penetrating deeply into the tumor vascular bed is another promising new option. Very effective devascularization of HCC nodules has been shown after 40 μm bland embolizations, however, potential risks like passage of particles into hepatic veins and systemic circulation have to be considered. Today the indication for TACE in intermediate stage HCC patients is widely accepted; however, there is no clear methodical standard so far. Further studies are necessary to define how to adapt various available methods to individual HCC and patients characteristics.Keywords
This publication has 27 references indexed in Scilit:
- Longitudinal Quality of Life Assessment of Patients with Hepatocellular Carcinoma after Primary Transarterial ChemoembolizationJournal of Vascular and Interventional Radiology, 2010
- Strategies for the management of hepatocellular carcinomaNature Clinical Practice Oncology, 2007
- Staging and Current Treatment of Hepatocellular CarcinomaRadioGraphics, 2005
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Chemoembolization for hepatocellular carcinomaGastroenterology, 2004
- Hepatocellular carcinomaThe Lancet, 2003
- Epidemiology and Clinical Presentation of Hepatocellular CarcinomaJournal of Vascular and Interventional Radiology, 2002
- Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinomaHepatology, 2002
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002
- Epidemiology of Primary Liver CancerSeminars in Liver Disease, 1999